Ascentage Pharma (06855): Trustee purchases 200,000 shares for the 2022 Restricted Share Unit Plan

Zhitong Finance APP News, Ascentage Pharma (06855) announced that on October 27, 2026, the trustee purchased a total of 200,000 existing shares on-market for the purpose of the 2022 Restricted Share Unit Scheme (the Purchased Shares) to satisfy Restricted Share Units upon vesting.